The EQuIP Study

  • Research type

    Research Study

  • Full title

    Development and validation of Emerging Quantitative Imaging techniques for assessing myocardial Perfusion - The EQuIP Study

  • IRAS ID

    276543

  • Contact name

    Amedeo Chiribiri

  • Contact email

    amedeo.chiribiri@kcl.ac.uk

  • Sponsor organisation

    King's College London

  • Duration of Study in the UK

    1 years, 2 months, 30 days

  • Research summary

    Cardiac magnetic resonance imaging (CMR) is recognised as one of the imaging methods of choice to investigate the heart. A technique called stress perfusion CMR, which involves giving patients a medication to increase their heart rate, is used to identify the diagnosis of chest pain. This allows the investigation of coronary artery disease (CAD)and problems with smaller blood vessels called microvascular disease (MVD), and differentiates these form other causes of chest pain such as structural changes of the heart (called cardiomyopathy) or inflammation of the heart muscle (called myocarditis).

    A dedicated team at King's College London and Guy's & St Thomas' NHS Foundation Trust have been involved in improving the diagnosis from stress perfusion CMR for the past decade. This research is an extension of this work, in a bid to improve comparability of data between different scanners, repeatability of methods and accuracy of emerging techniques in stress perfusion CMR.

    This study invites patients who are already being investigated for suspected cardiac issues via stress CMR to have a second comparable scan. This could be done on a different scanner or with methods not previously used during clinical scanning. This would allow new techniques to be tested and validated against existing methods used in clinical practice. Participation in the study is purely voluntary and all study data would be processed and stored anonymously to maintain patient confidentiality.

  • REC name

    North West - Haydock Research Ethics Committee

  • REC reference

    22/NW/0188

  • Date of REC Opinion

    24 Jun 2022

  • REC opinion

    Unfavourable Opinion